SCHEMBL916179

SCHEMBL916179

Brc1ccc(C2CO2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.56
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KDM1A O60341 5/20 0.44
KCNH2 Q12809 2/20 0.44
MAOB P27338 2/20 0.44
RCOR1 Q9UKL0 2/20 0.44
KDM1B Q8NB78 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
HTR2C P28335 2/20 0.43
HTR2B P41595 2/20 0.43
CYP2A6 P11509 1/20 0.42
MDM2 Q00987 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2238431 1.00 TSHR (0.56) TSHRSLC6A2SLC6A4SLC6A3KDM1A
SCHEMBL83447 1.00 TSHR (0.56) TSHRSLC6A2SLC6A4SLC6A3KDM1A
Methyl Alcohol SCHEMBL8767666 0.93 TSHR (0.50) TSHRSLC6A2SLC6A4SLC6A3KDM1A
SCHEMBL46155 0.86 TSHR (0.72) TSHR
SCHEMBL5853845 0.84 TSHR (0.41) TSHRSLC6A2SLC6A4SLC6A3KDM1A
SCHEMBL8250970 0.83 TSHR (0.40) TSHRSLC6A2SLC6A4SLC6A3KDM1A
SCHEMBL15348686 0.81 SLC6A2 (0.46) TSHRSLC6A2SLC6A4SLC6A3KDM1A
SCHEMBL17548454 0.80 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3KDM1AKCNH2
SCHEMBL17548027 0.80 KDM1A (0.38) TSHRSLC6A2SLC6A4SLC6A3KDM1A
SCHEMBL13606171 0.80 SLC6A2 (0.45) TSHRSLC6A2SLC6A4SLC6A3KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026099899-A1 AMINE FUNCTIONALIZED SILICA CATALYST FOR PREPARATION OF ORGANIC CARBONATE AND OTHER APPLICATIONS THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2026-05-15 WO claimed
US-20250281875-A1 SUBSTITUTED EPOXIDE MODIFIED SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS GLOBAL THERMOSTAT OPERATIONS LLC (US) 2025-09-11 US claimed
CN-119708491-A Polydisulfide polymer material containing hydroxy ester group and preparation method thereof 衢州化工新材料创新研究院 2025-03-28 CN claimed
EP-4519008-A2 SUBSTITUTED EPOXIDE MODIFIED SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS Global Thermostat Operations, LLC (US) 2025-03-12 EP claimed
CN-119325409-A Substituted epoxide modified adsorbents, systems including adsorbents, and methods of using adsorbents 全球温控营运有限责任公司 2025-01-17 CN claimed
CN-118563343-A Hydroboration reaction method for electrochemical catalysis of epoxy compound 南京林业大学 2024-08-30 CN claimed
CN-115927276-B Halohydrin dehalogenase mutant and application thereof in synthesis of chiral oxazolidinone 中国科学院天津工业生物技术研究所 2024-08-27 CN claimed
CN-117164875-A Preparation method of tubular metal copper phthalocyanine polymer and cyclic carbonate 浙江理工大学 2023-12-05 CN claimed
WO-2023215873-A2 SUBSTITUTED EPOXIDE MODIFIED SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS GLOBAL THERMOSTAT OPERATIONS, LLC. (US) 2023-11-09 WO claimed
CN-111217769-B Method for synthesizing epoxy compound by catalyzing olefin epoxy by using nano alumina 华南理工大学 2023-04-21 CN claimed
CN-115927276-A Halogen alcohol dehalogenase mutant and application thereof in synthesizing chiral oxazolidinone 中国科学院天津工业生物技术研究所 2023-04-07 CN claimed
EP-0605937-B1 Antistatic resin composition DAISO CO LTD (JP) 1997-06-11 EP claimed
EP-0605937-A1 Antistatic resin composition DAISO CO., LTD. (JP) 1994-07-13 EP claimed
WO-2026099899-A1 AMINE FUNCTIONALIZED SILICA CATALYST FOR PREPARATION OF ORGANIC CARBONATE AND OTHER APPLICATIONS THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2026-05-15 WO disclosed
US-12559486-B2 Tau-protein targeting compounds and associated methods of use ARVINAS OPERATIONS, INC. (US) 2026-02-24 US disclosed
US-20250281875-A1 SUBSTITUTED EPOXIDE MODIFIED SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS GLOBAL THERMOSTAT OPERATIONS LLC (US) 2025-09-11 US disclosed
EP-0605937-A1 Antistatic resin composition DAISO CO., LTD. (JP) 1994-07-13 EP disclosed
US-5130117-A Imaging agents; monitor effectiveness of drugs in nervous and mental disorders TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1992-07-14 US disclosed
EP-0391554-A1 Dopamine receptor ligands and imaging agents THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1990-10-10 EP disclosed
US-4315938-A ANTIDEPRESSANTS BOEHRINGER INGELHEIM GMBH (DE) 1982-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559486-B2 Tau-protein targeting compounds and associated methods of use UBQLN2, UBQLN1, CRBN TSHR 2915/4885SLC6A2 2791/4885SLC6A4 3182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.